🔗 Permalink

Assignee profile:

KINIKSA PHARMACEUTICALS, LTD.

City:

Hamilton

Country:

Bermuda

Published Applications:

Last publication date:

2022-09-08

Patent Grants:

Last grant date:

2024-10-22

Top Inventors for applications by KINIKSA PHARMACEUTICALS, LTD.

These are the the leading inventors for applications assigned to KINIKSA PHARMACEUTICALS, LTD.:

Sabine S. Escobar 5 Sammamish, WA United States
Ai Ching LIM 5 Mercer Island, WA United States
Nels E. Pederson 5 Mansfield, MA United States
Heather A. Arnett 5 Seattle, WA United States

Paul H. Weinreb 5 Weston, MA United States
Chadwick T. KING 5 North Vancouver, Canada
Saravanakumar Narayanan 5 Brookline, MA United States
Ryan Erik Holcomb 3 Johnstown, CO United States

Dave Nichols 3 Wellesley, MA United States
Zahra Shahrokh 3 Weston, MA United States
Mark Cornell Manning 3 Johnstown, CO United States
Phillip M. Levesque 2 Wellesley, MA United States

Philip M Levesque 1 Wellesley, MA United States
Dave Nichols 1 Lexington, MA United States
Chadwick T. King 1 North Vancouver, CA United States
Shaun Grier 1 Lexington, MA United States

Philip M Levesque 1 Wellesle, MA United States
Mei Jang 1 Lexington, MA United States
Baochuan Huang 1 Lexington, MA United States

Recent patent applications by KINIKSA PHARMACEUTICALS, LTD.

KINIKSA PHARMACEUTICALS, LTD. based in Hamilton, BM has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-09-08

US20220281914A1

Chemistry; metallurgy

PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME

#2 | 2022-02-24 ✅ Patent 12,122,837 granted on 2024-10-22

US20220056144A1

Chemistry; metallurgy

Oncostatin M receptor antigen binding proteins

#3 | 2020-02-27 ✅ Patent 11,141,479 granted on 2021-10-12

US20200061188A1

Human necessities

Stable anti-OSMR antibody formulation

#4 | 2019-02-21 ✅ Patent 10,391,170 granted on 2019-08-27

US20190054169A1

Human necessities

Stable anti-OSMR antibody formulation

#5 | 2018-11-22 ✅ Patent 10,493,149 granted on 2019-12-03

US20180333489A1

Human necessities

Stable anti-OSMR antibody formulation

#6 | 2018-01-04 ✅ Patent 10,421,813 granted on 2019-09-24

US20180002429A1

Chemistry; metallurgy

Oncostatin M receptor antigen binding proteins

#7 | 2017-08-03 ✅ Patent 9,738,721 granted on 2017-08-22

US20170218076A1

Chemistry; metallurgy

Oncostatin M receptor antigen binding proteins

#8 | 2017-01-12 ✅ Patent 9,593,163 granted on 2017-03-14

US20170008958A1

Chemistry; metallurgy

Oncostatin M receptor antigen binding proteins

#9 | 2016-05-19 ✅ Patent 9,663,571 granted on 2017-05-30

US20160137739A1

Chemistry; metallurgy

Oncostatin M receptor antigen binding proteins

Also check out Kiniksa Pharmaceuticals, Ltd.'s (Hamilton, Bermuda) applicant profile with 10 patent applications submitted.

AssigneeID:

327984 ⎘